{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:36:32Z","timestamp":1793046992347,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007378","name":"Associazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020956","name":"Merck Healthcare KGaA","doi-asserted-by":"publisher","award":["10.13039\/100,009,945"],"award-info":[{"award-number":["10.13039\/100,009,945"]}],"id":[{"id":"10.13039\/100020956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.msard.2025.106644","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T06:12:37Z","timestamp":1753683157000},"page":"106644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Lost in translation: rethinking animal models of progressive MS (an industry perspective)"],"prefix":"10.1016","volume":"103","author":[{"given":"Florian","family":"Von Raison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zaratin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Shimshek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Nuesslein-Hildesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnoosh","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Peelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hella","family":"Kohlhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nellwyn","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Piani","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Boschert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106644_bib0001","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106644_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93590-1","article-title":"Characterization of microglial transcriptomes in the brain and spinal cord of mice in early and late experimental autoimmune encephalomyelitis using a RiboTag strategy","volume":"11","author":"Acharjee","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2025.106644_bib0003","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021110002","article-title":"Do we still need animals? Surveying the role of animal-free models in Alzheimer's and Parkinson's disease research","volume":"41","author":"Aerts","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.msard.2025.106644_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106290","article-title":"B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis","volume":"187","author":"Ahn","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.msard.2025.106644_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.22054","article-title":"Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords","volume":"68","author":"Androdias","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106644_bib0006","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1097-4547(20000715)61:2<140::AID-JNR4>3.0.CO;2-X","article-title":"EAE susceptibility in FVB mice","volume":"61","author":"Baker","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.msard.2025.106644_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001756","article-title":"Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies","volume":"12","author":"Baker","year":"2014","journal-title":"PLoS. Biol."},{"key":"10.1016\/j.msard.2025.106644_bib0008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-018-0510-8","article-title":"Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945","volume":"6","author":"Beckmann","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.msard.2025.106644_bib0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2014.06.004","article-title":"From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development","volume":"54","author":"Ben-Nun","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.msard.2025.106644_bib0010","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/brain\/awab045","article-title":"Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition","volume":"144","author":"Bhargava","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106644_bib0011","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1093\/brain\/awac233","article-title":"Contribution of B cells to cortical damage in multiple sclerosis","volume":"145","author":"Bhargava","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106644_bib0012","first-page":"193","article-title":"Remyelination in experimental models of toxin-induced demyelination","volume":"318","author":"Blakemore","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.msard.2025.106644_bib0013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1352458518805246","article-title":"Animal models of multiple sclerosis: from rodents to zebrafish","volume":"25","author":"Burrows","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106644_bib0014","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamaneurol.2022.1025","article-title":"Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis","volume":"79","author":"Cagol","year":"2022","journal-title":"JAMa Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106644_bib0015","article-title":"Infection with murine gamma herpesvirus 68 modifies experimental autoimmune encephalomyelitis","volume":"186","author":"Casiraghi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2025.106644_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235615","article-title":"Imaging correlates of visual function in multiple sclerosis","volume":"15","author":"Caverzasi","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2025.106644_bib0017","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.msard.2025.106644_bib0018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","article-title":"Promoting remyelination in multiple sclerosis","volume":"268","author":"Cunniffe","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106644_bib0019","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/7854_2015_378","article-title":"Modelling MS: chronic-relapsing EAE in the NOD\/Lt mouse strain","volume":"26","author":"Dang","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.msard.2025.106644_bib0020","doi-asserted-by":"crossref","DOI":"10.1242\/bio.059845","article-title":"Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect","volume":"12","author":"Daviaud","year":"2023","journal-title":"Biol. Open."},{"key":"10.1016\/j.msard.2025.106644_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106230","article-title":"An overall view of the most common experimental models for multiple sclerosis","volume":"184","author":"Dedoni","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.msard.2025.106644_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2021.109088","article-title":"An optimized animal model of lysolecithin induced demyelination in optic nerve; more feasible, more reproducible, promising for studying the progressive forms of multiple sclerosis","volume":"352","author":"Dehghan","year":"2021","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.msard.2025.106644_bib0023","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001161","article-title":"Increased remyelination and proregenerative microglia under Siponimod therapy in mechanistic models","volume":"9","author":"Dietrich","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106644_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40263-022-00977-3","article-title":"Treatment of patients with multiple sclerosis transitioning between relapsing and progressive disease","volume":"37","author":"Dimitriou","year":"2023","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.msard.2025.106644_bib0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/d41573-019-00074-z","article-title":"Trends in clinical success rates and therapeutic focus","volume":"18","author":"Dowden","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.msard.2025.106644_bib0026","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/13524585231162262","article-title":"Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis","volume":"29","author":"Elliott","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106644_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813893","article-title":"An animal model for chronic meningeal inflammation and inflammatory demyelination of the cerebral cortex","volume":"24","author":"Enz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106644_bib0028","unstructured":"(2017). European Medicines Agency Science Medicines Health. Assessment report Ocrevus International non-proprietary name: ocrelizumab Procedure No. EMEA\/H\/C\/004043\/0000."},{"key":"10.1016\/j.msard.2025.106644_bib0029","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","article-title":"Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis","volume":"24","author":"Falcao","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2025.106644_bib0030","doi-asserted-by":"crossref","DOI":"10.1007\/s10334-024-01160-z","article-title":"Magnetic resonance metrics for identification of cuprizone-induced demyelination in the mouse model of neurodegeneration: a review","author":"Friesen","year":"2024","journal-title":"MAGMa"},{"key":"10.1016\/j.msard.2025.106644_bib0031","article-title":"Spatial transcriptomics of meningeal inflammation reveals variable penetrance of inflammatory gene signatures into adjacent brain parenchyma","volume":"12","author":"Gadani","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.msard.2025.106644_bib0032","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-024-02730-0","article-title":"BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair","volume":"147","author":"Geladaris","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2025.106644_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040945","article-title":"Delayed demyelination and impaired remyelination in aged mice in the Cuprizone model","volume":"9","author":"Gingele","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.msard.2025.106644_bib0034","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2025.106644_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.msard.2025.106644_bib0036","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12974-023-02922-7","article-title":"BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions","volume":"20","author":"Gupta","year":"2023","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2025.106644_bib0037","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41419-020-03084-7","article-title":"CSF1R signaling is a regulator of pathogenesis in progressive MS","volume":"11","author":"Hagan","year":"2020","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.msard.2025.106644_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117425","article-title":"Machine learning based white matter models with permeability: an experimental study in cuprizone treated in-vivo mouse model of axonal demyelination","volume":"224","author":"Hill","year":"2021","journal-title":"Neuroimage"},{"key":"10.1016\/j.msard.2025.106644_bib0039","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200083","article-title":"Ocrelizumab treatment modulates B-cell regulating factors in multiple sclerosis","volume":"10","author":"Ho","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106644_bib0040","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.neuron.2021.07.015","article-title":"The continued need for animals to advance brain research","volume":"109","author":"Homberg","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.msard.2025.106644_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112293","article-title":"Transcriptomic atlas and interaction networks of brain cells in mouse CNS demyelination and remyelination","volume":"42","author":"Hou","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.msard.2025.106644_bib0042","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40265-021-01526-w","article-title":"Failed, interrupted, or inconclusive trials on neuroprotective and neuroregenerative treatment strategies in Multiple sclerosis: update 2015-2020","volume":"81","author":"Huntemann","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.msard.2025.106644_bib0043","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.msard.2025.106644_bib0044","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science (1979)"},{"key":"10.1016\/j.msard.2025.106644_bib0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","article-title":"Locus for severity implicates CNS resilience in progression of multiple sclerosis","volume":"619","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106644_bib0046","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/d41586-024-02314-8","article-title":"Animal research is not always king: researchers should explore the alternatives","volume":"631","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106644_bib0047","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"Jakel","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106644_bib0048","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.25263","article-title":"Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis","volume":"84","author":"Jia","year":"2018","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106644_bib0049","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2014.03.006","article-title":"Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis","volume":"160","author":"Jiang","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.msard.2025.106644_bib0050","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/glia.23937","article-title":"Cuprizone-induced demyelination triggers a CD8-pronounced T cell recruitment","volume":"69","author":"Kaddatz","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.msard.2025.106644_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262677","article-title":"Local autoimmune encephalomyelitis model in a rat brain with precise control over lesion placement","volume":"17","author":"Kalkowski","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2025.106644_bib0052","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106644_bib0053","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.medj.2021.01.006","article-title":"Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis","volume":"2","author":"Kaufmann","year":"2021","journal-title":"Med."},{"key":"10.1016\/j.msard.2025.106644_bib0054","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41593-022-01097-3","article-title":"Identification of early neurodegenerative pathways in progressive multiple sclerosis","volume":"25","author":"Kaufmann","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"2 supplement","key":"10.1016\/j.msard.2025.106644_bib0055","first-page":"88","article-title":"The Bruton\u2019s tyrosine kinase inhibitor evobrutinib demonstrates superior efficacy in targeting compartmentalized neuroinflammation compared to anti-CD20 treatment","volume":"29","author":"Kebir","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106644_bib0056","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106644_bib0057","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2025.106644_bib0058","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","article-title":"Roles of neuropathology-associated reactive astrocytes: a systematic review","volume":"11","author":"Lawrence","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.msard.2025.106644_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.117744","article-title":"Can MRI measure myelin? Systematic review, qualitative assessment, and meta-analysis of studies validating microstructural imaging with myelin histology","volume":"230","author":"Lazari","year":"2021","journal-title":"Neuroimage"},{"key":"10.1016\/j.msard.2025.106644_bib0060","series-title":"Multi-Parametric MRI Can Detect Enhanced Myelination in the Gli1 (-\/-) Mouse Brain","author":"Lee","year":"2024"},{"key":"10.1016\/j.msard.2025.106644_bib0061","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12264-015-1555-3","article-title":"Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination","volume":"31","author":"Li","year":"2015","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.msard.2025.106644_bib0062","series-title":"A 4D Transcriptomic Map For the Evolution of Multiple Sclerosis-Like Lesions in the Marmoset Brain","author":"Lin","year":"2023"},{"issue":"6737","key":"10.1016\/j.msard.2025.106644_bib0063","article-title":"4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis-like lesions","volume":"387","author":"Lin","year":"2025","journal-title":"Science (1979)"},{"key":"10.1016\/j.msard.2025.106644_bib0064","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2009.02.004","article-title":"Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination","volume":"453","author":"Lindner","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.msard.2025.106644_bib0065","first-page":"1","article-title":"Human disease models in drug development","author":"Loewa","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"issue":"Suppl 1","key":"10.1016\/j.msard.2025.106644_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000367614","article-title":"New multiple sclerosis phenotypic classification","volume":"72","author":"Lublin","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2025.106644_bib0067","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106644_bib0068","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2025.106644_bib0069","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jnr.25173","article-title":"Cell reprogramming for oligodendrocytes: a review of protocols and their applications to disease modeling and cell-based remyelination therapies","volume":"101","author":"McCaughey-Chapman","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.msard.2025.106644_bib0070","doi-asserted-by":"crossref","DOI":"10.1038\/srep43545","article-title":"Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple sclerosis","volume":"7","author":"Medina-Rodriguez","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2025.106644_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104675","article-title":"Laquinimod ameliorates secondary brain inflammation","volume":"134","author":"Nedelcu","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.msard.2025.106644_bib0072","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.171.1.462","article-title":"Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL\/6 mice","volume":"171","author":"Oliver","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2025.106644_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111189","article-title":"Disease-associated oligodendrocyte responses across neurodegenerative diseases","volume":"40","author":"Pandey","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.msard.2025.106644_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1019799","article-title":"Theiler's virus-induced demyelinating disease as an infectious model of progressive multiple sclerosis","volume":"15","author":"Pike","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.msard.2025.106644_bib0075","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5371","article-title":"Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)","volume":"53","author":"Qin","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.msard.2025.106644_bib0076","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200278","article-title":"Single-cell RNA sequencing reveals transcriptional landscape of neutrophils and highlights the role of TREM-1 in EAE","volume":"11","author":"Quan","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106644_bib0077","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bpa.12841","article-title":"B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis","volume":"30","author":"Reali","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2025.106644_bib0078","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jnr.24528","article-title":"Biological models in multiple sclerosis","volume":"98","author":"Sanabria-Castro","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.msard.2025.106644_bib0079","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"Schirmer","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106644_bib0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.it.2021.01.005","article-title":"Diversity and function of glial cell types in multiple sclerosis","volume":"42","author":"Schirmer","year":"2021","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.msard.2025.106644_bib0081","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/glia.24148","article-title":"The roles of microglia and astrocytes in phagocytosis and myelination: insights from the cuprizone model of multiple sclerosis","volume":"70","author":"Sen","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.msard.2025.106644_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.631548","article-title":"Rapid and efficient generation of myelinating Human oligodendrocytes in organoids","volume":"15","author":"Shaker","year":"2021","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.msard.2025.106644_bib0083","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/acschemneuro.4c00024","article-title":"Targeted-neuroinflammation mitigation using inflammasome-inhibiting nanoligomers is therapeutic in an experimental autoimmune encephalomyelitis mouse model","volume":"15","author":"Sharma","year":"2024","journal-title":"ACS. Chem. Neurosci."},{"key":"10.1016\/j.msard.2025.106644_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108835","article-title":"Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination","volume":"34","author":"Shen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.msard.2025.106644_bib0085","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41374-021-00646-x","article-title":"Recombinant myelin oligodendrocyte glycoprotein quality modifies evolution of experimental autoimmune encephalitis in macaques","volume":"101","author":"Stimmer","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.msard.2025.106644_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104789","article-title":"Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis","volume":"96","author":"Touil","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.msard.2025.106644_bib0087","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1352458507084264","article-title":"Natural history of secondary-progressive multiple sclerosis","volume":"14","author":"Tremlett","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106644_bib0088","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-021-02293-4","article-title":"Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration","volume":"141","author":"van Olst","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2025.106644_bib0089","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/s41418-023-01195-0","article-title":"Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression","volume":"30","author":"Van San","year":"2023","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.msard.2025.106644_bib0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-2094-10-35","article-title":"Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status","volume":"10","author":"Vogel","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106644_bib0091","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106644_bib0092","doi-asserted-by":"crossref","first-page":"eadi0295","DOI":"10.1126\/scitranslmed.adi0295","article-title":"B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans","volume":"16","author":"Wang","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.msard.2025.106644_bib0093","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/7651_2014_177","article-title":"Actively induced experimental autoimmune encephalomyelitis in rats","volume":"1304","author":"Weissert","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.msard.2025.106644_bib0094","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.msard.2018.09.025","article-title":"Leptomeningeal inflammation in multiple sclerosis: insights from animal and human studies","volume":"26","author":"Wicken","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106644_bib0095","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00115-021-01157-2","article-title":"[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]","volume":"92","author":"Wiendl","year":"2021","journal-title":"Nervenarzt."},{"key":"10.1016\/j.msard.2025.106644_bib0096","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18396","article-title":"Role of ferroptosis in neuroimmunity and neurodegeneration in multiple sclerosis revealed by multi-omics data","volume":"28","author":"Wu","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.msard.2025.106644_bib0097","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jnc.15142","article-title":"Acute motor deficit and subsequent remyelination-associated recovery following internal capsule demyelination in mice","volume":"156","author":"Yamazaki","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2025.106644_bib0098","first-page":"9","article-title":"The cuprizone model: dos and do nots","author":"Zhan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.msard.2025.106644_bib0099","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/imm.13395","article-title":"Ectopic lymphoid follicles in progressive multiple sclerosis: from patients to animal models","volume":"164","author":"Zhan","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.msard.2025.106644_bib0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.expneurol.2015.02.006","article-title":"Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination","volume":"266","author":"Zhang","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.msard.2025.106644_bib0101","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158144","article-title":"Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation","volume":"7","author":"Zuo","year":"2022","journal-title":"JCI. Insight."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:30:03Z","timestamp":1778841003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825003864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":101,"alternative-id":["S2211034825003864"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106644","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lost in translation: rethinking animal models of progressive MS (an industry perspective)","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106644"}}